Psychedelics

Clinical Trials Psilocybin MDMA Therapeutic Effects DMT LSD Neurobiology Ibogaine Effects

Psilocybin Therapy Puts Most Veterans With Treatment‑Resistant PTSD Into Remission

A small safety‑focused pilot produced high one‑month remission rates, prompting plans for larger randomized trials and further federal review of psychedelic treatments.

5 ARTICLES

2mo ago

High‑Dose Psilocybin Sessions Produced Temporary Gains in an Elderly Alzheimer’s Patient

5 ARTICLES

3mo ago

FDA Clears First U.S. Trial of Ibogaine Derivative After Trump Order

6 ARTICLES

6mo ago

Single IV DMT Dose With Therapy Shows Rapid, Lasting Antidepressant Effect in Phase IIa Trial

3 ARTICLES

11mo ago

Five-Year Follow-Up Finds 67% Remission After Psilocybin-Assisted Therapy

12 ARTICLES

11mo ago

Single 100-Microgram Dose of LSD Drug Eased GAD for 12 Weeks in JAMA Trial

6 ARTICLES

last yr.

Single Psilocybin Dose Delivers Two-Year Relief From Depression and Anxiety in Cancer Patients

3 ARTICLES

last yr.

Psilocybin Therapy Shows Promise for Millions with Depression

8 ARTICLES

2y ago

FDA Declines MDMA for PTSD Treatment, Requests Further Trials